StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CareRx Corporation
Toronto Stock Exchange:CRRX.TO
Sector
Location
Market Cap
USD 136.60 M
Share Price
USD 2.16
Avg Daily Volume
43,588
Change (1 day)
-0.92%
Change (1 year)
35.85%
Change (YTD)
50.97%
CareRx Corporation EBITDA for the year ending December 31, 2024: USD 16.61 M
CareRx Corporation EBITDA is USD 16.61 M for the year ending December 31, 2024, a -10.69% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
CareRx Corporation EBITDA for the year ending December 31, 2023 was USD 18.60 M, a -4,233.18% change year over year.
-
CareRx Corporation EBITDA for the year ending December 31, 2022 was USD -450.00 K, a -106.32% change year over year.
-
CareRx Corporation EBITDA for the year ending December 31, 2021 was USD 7.12 M, a 118.55% change year over year.
-
CareRx Corporation EBITDA for the year ending December 31, 2020 was USD 3.26 M, a -172.80% change year over year.
Competitors
Chemed Corporation
USD 459.91
CHE
-5.77
-1.24%
UnitedHealth Group Incorporated
USD 304.10
UNH
+4.59
1.53%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
McKesson Corporation
USD 709.59
MCK
-4.95
-0.69%
CVS Health Corporation
USD 64.78
CVS
-0.84
-1.28%
Elevance Health Inc.
USD 340.67
ELV
-5.19
-1.50%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Cardinal Health, Inc.
USD 160.97
CAH
-1.20
-0.74%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Humana Inc.
USD 230.67
HUM
-1.51
-0.65%
JD Health International Inc.
USD 5.43
6618.HK
-0.01
-0.23%
Fresenius Medical Care AG & Co. KGaA
USD 54.07
FME.DE
-0.85
-1.55%
Encompass Health Corporation
USD 118.43
EHC
+0.94
0.80%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.57
2607.HK
+0.01
0.49%
Demant A/S
USD 41.20
DEMANT.CO
-0.99
-2.35%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.17
2196.HK
+0.01
0.59%
The Ensign Group, Inc.
USD 143.98
ENSG
-1.75
-1.20%
Sinopharm Group Co. Ltd.
USD 2.40
1099.HK
+0.02
0.64%
Stevanato Group S.p.A.
USD 25.21
STVN
-0.73
-2.81%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.18
002653.SZ
-0.28
-4.36%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Chemed Corporation
USD 459.91
CHE
-5.77
-1.24%
UnitedHealth Group Incorporated
USD 304.10
UNH
+4.59
1.53%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
McKesson Corporation
USD 709.59
MCK
-4.95
-0.69%
CVS Health Corporation
USD 64.78
CVS
-0.84
-1.28%
Elevance Health Inc.
USD 340.67
ELV
-5.19
-1.50%
Cencora, Inc.
USD 295.21
COR
-2.11
-0.71%
Cardinal Health, Inc.
USD 160.97
CAH
-1.20
-0.74%
BeOne Medicines Ltd.
USD 250.30
ONC
-3.09
-1.22%
Humana Inc.
USD 230.67
HUM
-1.51
-0.65%
JD Health International Inc.
USD 5.43
6618.HK
-0.01
-0.23%
Fresenius Medical Care AG & Co. KGaA
USD 54.07
FME.DE
-0.85
-1.55%
Encompass Health Corporation
USD 118.43
EHC
+0.94
0.80%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.57
2607.HK
+0.01
0.49%
Demant A/S
USD 41.20
DEMANT.CO
-0.99
-2.35%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.17
2196.HK
+0.01
0.59%
The Ensign Group, Inc.
USD 143.98
ENSG
-1.75
-1.20%
Sinopharm Group Co. Ltd.
USD 2.40
1099.HK
+0.02
0.64%
Stevanato Group S.p.A.
USD 25.21
STVN
-0.73
-2.81%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.18
002653.SZ
-0.28
-4.36%